Organovo Holdings, Inc. Organovo Holdings, Inc.

Organovo Holdings, Inc.

ONVO

Rang in aandelen #36075
Organovo Holdings, Inc. is a biotechnology firm that specializes in engineering... Organovo Holdings, Inc. is a biotechnology firm that specializes in engineering sophisticated 3D tissues designed to accurately mimic critical facets of human diseases. Central to its operations is a comprehensive 3D human tissue platform, which features the company's proprietary NovoGen Bioprinters. These automated devices are crucial for fabricating complex, living 3D tissues from mammalian cells. The platform also includes supporting technologies necessary for creating specialized "bio-inks" and for the bioprinting of multi-cellular tissues with intricate structures. Organovo supplies specific products, such as ExVive human liver tissue and ExVive human kidney tissue, which are employed for predictive preclinical evaluation of investigational drug compounds. The company was founded in 2007 and maintains its corporate headquarters in Solana Beach, California.
Aandeelprijs
$2.00
Laatst gesynchroniseerd: 2025-05-19
Marktkapitalisatie
$2.93M
Verandering (1 dag)
-3.38%
Verandering (1 jaar)
656.14%
Land
US
Handel Organovo Holdings, Inc. (ONVO)

Categorie

Healthcare
Dividendgeschiedenis van Organovo Holdings, Inc. (ONVO)
Organovo Holdings, Inc. (aandelsymbool: ONVO) heeft in totaal 0 dividenduitkeringen gedaan.
De som van alle dividenden (aangepast voor aandelensplitsingen) is: 0.00
Dividendrendement (TTM): 0
Dividendbetalingen voor Organovo Holdings, Inc. (ONVO) van 2026 tot 2026
Jaarlijkse dividendbetalingen
Jaar Dividend (aangepast voor aandelensplitsingen) Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Lijst van alle dividendbetalingen
Jaar Dividend Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendbetalingen voor vergelijkbare bedrijven of concurrenten
Bedrijf Aantal dividendbetalingen Land
0.00%
US
0.00%
US
64.00%
AU
0.00%
CH
0.00%
NL